Twist Bioscience (TWST) Short term Debt (2018 - 2021)

Twist Bioscience (TWST) has reported Short term Debt for 4 consecutive years, with $9.1 million the latest figure, recorded in Q4 2021.

• On a quarterly basis, Short term Debt rose 172.49% year-over-year to $9.1 million in Q4 2021; TTM through Dec 2021 was $9.1 million, a 172.49% increase from a year earlier, with the FY2021 full-year figure at $1.6 million, down 53.44% from the prior year.
• Short term Debt was $9.1 million for Q4 2021 at Twist Bioscience, up from $1.6 million in the prior quarter.
• Over five years, Short term Debt peaked at $9.1 million in Q4 2021 and troughed at $1.6 million in Q3 2021.
• A 4-year average of $3.5 million and a median of $3.3 million in 2018 frame the typical range for Short term Debt.
• The widest YoY moves for Short term Debt: up 172.49% in 2021, down 53.44% in 2021.
• Over 4 years, Short term Debt stood at $3.3 million in 2018, then changed by 0.0% to $3.3 million in 2019, then changed by 0.0% to $3.3 million in 2020, then soared by 172.49% to $9.1 million in 2021.
• The last three Short term Debt figures came in at $9.1 million (Q4 2021), $1.6 million (Q3 2021), and $2.4 million (Q2 2021), per Business Quant data.